CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Continente #
NA - Nord America 20.934
AS - Asia 13.916
EU - Europa 9.992
SA - Sud America 1.624
Continente sconosciuto - Info sul continente non disponibili 1.190
AF - Africa 311
OC - Oceania 81
Totale 48.048
Nazione #
US - Stati Uniti d'America 19.781
SG - Singapore 4.643
CN - Cina 2.825
VN - Vietnam 2.685
IT - Italia 2.501
DE - Germania 1.568
HK - Hong Kong 1.466
RU - Federazione Russa 1.292
BR - Brasile 1.207
SE - Svezia 1.074
CA - Canada 958
IE - Irlanda 834
GB - Regno Unito 559
UA - Ucraina 555
FR - Francia 453
IN - India 452
KR - Corea 336
FI - Finlandia 266
BD - Bangladesh 259
ID - Indonesia 204
JP - Giappone 171
AR - Argentina 159
AT - Austria 155
TR - Turchia 148
NL - Olanda 138
IQ - Iraq 126
MX - Messico 106
ZA - Sudafrica 104
ES - Italia 99
PK - Pakistan 99
PL - Polonia 87
DK - Danimarca 80
LT - Lituania 80
CH - Svizzera 64
SA - Arabia Saudita 62
AU - Australia 60
BE - Belgio 56
EC - Ecuador 55
PH - Filippine 55
CO - Colombia 51
VE - Venezuela 50
IR - Iran 48
MY - Malesia 43
EG - Egitto 39
CL - Cile 33
UZ - Uzbekistan 32
AE - Emirati Arabi Uniti 30
PY - Paraguay 29
TW - Taiwan 29
MA - Marocco 28
TN - Tunisia 27
RO - Romania 26
KZ - Kazakistan 25
KE - Kenya 24
ET - Etiopia 23
IL - Israele 23
EU - Europa 20
TH - Thailandia 20
JO - Giordania 18
NZ - Nuova Zelanda 18
NP - Nepal 17
CR - Costa Rica 14
DZ - Algeria 14
OM - Oman 14
PS - Palestinian Territory 14
UY - Uruguay 14
AO - Angola 13
AZ - Azerbaigian 13
BO - Bolivia 13
CZ - Repubblica Ceca 13
JM - Giamaica 12
BG - Bulgaria 11
HN - Honduras 11
PE - Perù 11
PT - Portogallo 11
HR - Croazia 9
HU - Ungheria 9
KG - Kirghizistan 9
LB - Libano 9
NI - Nicaragua 9
AL - Albania 8
BH - Bahrain 8
MD - Moldavia 7
NG - Nigeria 7
NO - Norvegia 7
PA - Panama 7
RS - Serbia 7
GR - Grecia 6
KW - Kuwait 6
SN - Senegal 6
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
BB - Barbados 4
LV - Lettonia 4
SY - Repubblica araba siriana 4
Totale 46.814
Città #
Singapore 2.888
Ann Arbor 2.460
Ashburn 1.718
Dallas 1.522
San Jose 1.512
Hong Kong 1.407
Milan 968
Woodbridge 854
Dublin 814
Ho Chi Minh City 804
Chandler 791
Frankfurt am Main 774
Houston 657
Toronto 656
Hanoi 636
Wilmington 553
Jacksonville 547
New York 533
Fairfield 480
Santa Clara 454
Council Bluffs 453
Los Angeles 440
Dearborn 436
Beijing 421
Boardman 300
Chicago 300
Princeton 284
Hefei 273
Seoul 254
Seattle 233
The Dalles 226
Nanjing 190
Rome 183
Columbus 179
Shanghai 176
Buffalo 161
Lauterbourg 161
Cambridge 143
Jakarta 139
Vienna 136
Helsinki 119
São Paulo 114
Guangzhou 109
Moscow 106
Orem 106
Munich 91
Da Nang 89
Lachine 84
Lawrence 83
Tokyo 82
Dong Ket 77
Haiphong 76
Altamura 74
Chennai 69
Phoenix 68
Denver 63
Montreal 61
Nanchang 60
Shenyang 60
London 59
Vilnius 57
Atlanta 55
Brooklyn 55
Baghdad 53
Ha Long 52
Hải Dương 52
Pune 52
Warsaw 50
Andover 49
Carate Brianza 49
Nuremberg 48
Amsterdam 47
Biên Hòa 46
Zurich 46
Grafing 45
Johannesburg 45
San Diego 44
Can Tho 43
Changsha 43
Stockholm 43
Falls Church 42
San Francisco 42
Jinan 41
Fremont 40
Basingstoke 38
Bắc Ninh 38
Zhengzhou 38
Brussels 37
Rio de Janeiro 37
Tianjin 37
Jiaxing 35
Ninh Bình 35
Nürnberg 35
Poplar 35
Dhaka 34
Hangzhou 34
Washington 33
Boston 32
Kunming 32
Manchester 32
Totale 29.467
Nome #
CIPN and its mechanism of development 648
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 623
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 590
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 517
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 510
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 474
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 461
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 460
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 442
Age-related changes in the function and structure of the peripheral sensory pathway in mice 425
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 422
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 422
Enhanced brain targeting of engineered solid lipid nanoparticles 412
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 409
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 409
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 403
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 395
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 390
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 386
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 381
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 375
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 371
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 371
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 363
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 350
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 344
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 344
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 339
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 335
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 333
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 333
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 332
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 330
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 326
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 323
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 322
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 321
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 320
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 318
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 316
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 312
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 312
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 312
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 310
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 308
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 305
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 304
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 303
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 302
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 302
OCT2 transporter involvement in development of cisplatin toxicity 301
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 300
Intraepidermal nerve fiber density in rat foot pad: Neuropathologic- neurophysiologic correlation 295
In vivo study of Carfilzomib-Induced Neuropathy 295
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 294
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 293
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 292
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 290
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 288
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 288
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 285
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 283
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 283
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 283
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 281
Enhanced brain targeting of engineered solid lipid nanoparticles 281
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 279
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 279
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 279
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 276
Effect of proteasome inhibition on the central and peripheral nervous system 275
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 272
Multimodal experimental approach to the study of human neurological diseases 272
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 270
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 268
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 268
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 267
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 267
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 264
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 264
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 262
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 262
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 261
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 260
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 259
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 259
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 257
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 255
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 255
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 254
Genetic factors influencing the development of vincristine-induced neurotoxicity 254
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 253
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 253
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 252
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 252
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 251
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 251
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 251
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 250
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 249
Totale 32.547
Categoria #
all - tutte 147.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.761 0 194 143 200 168 212 91 89 91 133 144 296
2022/20233.443 363 879 319 353 269 531 61 174 273 56 102 63
2023/20242.890 96 105 105 131 345 701 518 176 136 65 65 447
2024/20257.326 383 823 683 329 578 304 500 254 770 972 612 1.118
2025/202620.920 2.708 1.788 2.372 1.707 1.841 1.079 2.724 971 1.559 1.671 1.212 1.288
2026/20271.453 843 610 0 0 0 0 0 0 0 0 0 0
Totale 48.048